A pharmacist based in Washington County, Pennsylvania, was sentenced in federal court in Pittsburgh for a prescription drug fraud scheme. The convictions were for obtaining controlled substances by fraud, misbranding of drugs, and conspiracy to commit health care fraud. The defendant owned and operated four pharmacies in the Pittsburgh region.
Unlike bedside diversion cases, this one sat at the ownership and dispensing-record level of a small pharmacy chain, where controlled substances were obtained by fraud and drugs were misbranded. The health care fraud conspiracy count indicates billing exposure alongside the controlled substance conduct.
The case resolved by guilty plea in September 2021, with sentencing following in May 2022. The court imposed a year of incarceration, two years of supervised release, a $10,000 fine, and $649,524 in restitution, announced by the United States Attorney for the Western District of Pennsylvania.
The restitution figure, which far exceeds the fine, reflects the financial loss attributed to the scheme rather than any penalty tied to the quantity of controlled substances involved. The announcement does not describe the detection pathway or the institutional changes that followed.